Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

DynPort LLC

DynPort Vaccine Company focuses on the advanced development of critical vaccines.


Contact Details:
Tel:
Fax:301-607-5099
Email:waltern@dvchq.com
WWW:

www.dynport.com/




BioNews Results for DynPort LLC:

Delcath Systems, Inc. Prices $30.6 Million Stock Offering
KOTA Territory News:  Nov 14 2009 11:05PM Matching: llc
Delcath Systems, Inc. Prices $30.6 Million Stock Offering
KSLA:  Nov 14 2009 7:28AM Matching: llc
Pharmaceuticals : EmailWire.Com SEO Press Release Distribution Services and PharmaNewsWire.Com Present Free Pharmaceutical Magazines
Earthtimes.org:  Nov 14 2009 8:08PM Matching: llc
Estimates of Cancer Potency of 2,3,7,8-Tetrachlorodibenzo(p)dioxin Using Linear and Nonlinear Dose-Response Mo
Toxicological Sciences:  Nov 14 2009 2:43AM Matching: llc
Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Genetic Engineering News:  Nov 13 2009 9:02AM Matching: llc
Promote your company here: BioNewsCast - Press Release Distribution

View more DynPort LLC news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 248 times since April 2007, the link to the organisation's website has been followed 59 times



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DynPort LLC

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.